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Commentary
The use of anthrax as a model system dates back to the 
late 19th century and Koch’s initial investigations into the 
transmission of infectious diseases (Koch, 1877). These 
studies, coupled with his subsequent investigations into 
tuberculosis, enabled Koch to formulate the first set of 
rules that were used to determine the etiology of a 
human infectious disease. Koch’s postulates, as these 
rules came to be known, have been used successfully by 
generations of microbe hunters, and have secured a spe-
cial place for anthrax in the history of medicine.
Anthrax continues to serve as a useful model system, 
with  studies  of  anthrax  toxin,  the  causative  agent  of   
anthrax, yielding insights into bacterial pathogenesis 
(Young and Collier, 2007), gating and permeation of 
ion channels (Blaustein et al., 1989, 1990; Blaustein and 
Finkelstein,  1990a,b;  Anderson  and  Blaustein,  2008), 
and transport of proteins across membranes (Collier, 
2009). It is this last topic—protein translocation—that 
is the focus of the paper by Basilio et al. in this issue.   
In particular, the authors address the following question: 
must the lethal factor (LF) component of anthrax toxin 
shed all of its secondary structure as it tunnels through 
the  channel  formed  by  the  protective  antigen  (PA) 
component, or can it retain most of its -helical nature? 
Because the usual JGP reader is likely less familiar with 
anthrax toxin channels than with the typical panoply of 
voltage-gated channels in excitable tissue, it will be help-
ful to first review some features of this system before 
delving into the experiments that address the transloca-
tion question.
Anthrax infection results from exposure to Bacillus 
anthracis, a gram-positive spore-forming bacterium that 
is found in soil and in the hair or hides of contaminated 
animals (Collier and Young, 2003). Although isolated 
skin contact typically causes only a localized infection in 
humans, inhalation of aerosolized spores can lead to   
a hemorrhagic invasive lung disease that is often fatal 
(Meselson et al., 1994). Cellular injury and death result 
from the action of anthrax toxin, a tripartite toxin com-
posed of a pore-forming subunit called protective anti-
gen (PA), so-named because of its use in generating 
vaccines, and two distinct enzymatically active subunits: 
LF and edema factor (EF) (Smith and Stoner, 1967; 
Smith, 2000).
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Pathogenesis relies on receptor-mediated endocyto-
sis, vesicular acidification, pore formation in the endo-
somal membrane by a PA-derived oligomer, and eventual 
translocation of EF and LF through this pore into the 
cytosol (Young and Collier, 2007). Once there, LF acts as 
a zinc-dependent protease that disrupts cellular signal-
ing by cleaving proteins of the mitogen-activated pro-
tein kinase kinase family (Duesbery et al., 1998), and EF 
is a calcium- and calmodulin-dependent adenylate cyclase 
that induces high levels of cAMP in mammalian cells 
(Leppla, 1982).
This route of intoxication is characteristic of the A/B 
family of toxins, a term coined by Gill to describe toxins 
that contain an active (A) domain—typically an enzyme 
that disrupts an important cellular process—and a bind-
ing (B) moiety that somehow mediates entry of the   
A fragment into the cytosol. Members of this family in-
clude the dichain toxins ricin, diphtheria, tetanus, and 
botulinum (Gill, 1978).
A fascinating property shared by the B fragments of 
many A/B toxins is that they form ion-conducting chan-
nels in lipid bilayers, with pore formation optimal under 
conditions that mirror those in an acidified endosome 
(Donovan et al., 1981; Kagan et al., 1981; Hoch and 
Finkelstein,  1985;  Hoch  et  al.,  1985;  Blaustein  et  al., 
1987; Gambale and Montal, 1988). With the exception 
of anthrax (discussed below), little is known about the 
molecular architecture of these channels. Nevertheless, 
given this channel-forming ability, along with the knowl-
edge that the soluble A fragments must cross a lipid 
membrane to reach the cytosol, it is tempting to specu-
late that these B fragments act as tunnel proteins to   
accommodate the membrane translocation of their   
A fragment partners. Sorting out the connection between 
channel formation (which, after all, involves the move-
ment of small inorganic ions) and translocation of pro-
teins has proved to be very challenging, however, and 
anthrax is the only toxin for which translocation of   
A through B has been convincingly demonstrated.
The pore-forming capability of PA resides in a 63-kD 
fragment (PA63) generated by proteolytic cleavage of 
whole PA (Blaustein et al., 1989). Purified PA63 forms 
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the large size and membrane impenetrability of strepta-
vidin. This general method has since been extended to 
the study of voltage sensor movements of voltage-gated 
K
+ channels in lipid bilayers (Jiang et al., 2003; Ruta   
et al., 2005; Banerjee and MacKinnon, 2008) and oocytes 
(Darman et al., 2006), and it forms the basis of the 
approach taken by Basilio et al. (2011).
To determine the secondary structure of LFN during 
translocation, Basilio et al. (2011) introduced an inter-
esting twist to the biotin-streptavidin capture strategy: 
molecular stoppers that allow LFN to be trapped in the 
PA63 pore. The authors used LFN constructs in which a 
stopper—either  biotin  or  yellow  fluorescent  protein 
(YFP)—was incorporated some distance away from the 
N-terminal biotin group. When added to the cis side of 
a PA63-containing bilayer held at +20 mV, the biotinyl-
ated N terminus of this LFN construct will enter the 
channel and work its way toward the trans side of the 
pore until the stopper impedes further translocation.   
If the distance between the N terminus and the stopper is 
long enough, streptavidin added to the trans side will 
grab the N-terminal biotin group and prevent LFN from 
unblocking to the cis side. If that distance is too short, 
trans streptavidin will have no effect. By examining a se-
ries of LFNs in this manner, each with a different num-
ber of residues between its stopper and its N terminus, 
the  authors  were  able  to  determine  a  cutoff  for  the 
number of amino acids required to span the channel.
Crucial to this approach is knowing where in the chan-
nel the stopper gets held up, which in turn relies on 
understanding both the nature of the stopper and the 
structure of the channel. There is reasonable evidence 
that both biotin and YFP can get inside the channel’s 
wide vestibule on the cis side of the membrane, but that 
they are unable to pass through the ring of phenyl-
alanines that comprise the -clamp (indicated by the red 
arrow in Fig. 1 of Basilio et al., 2011). This likely accounts 
for the observation that, despite their rather different 
structures, the biotin and YFP stoppers yield similar cut-
offs (33 residues) when blocking from the cis side of 
the bilayer. (Fortunately, the authors do discuss the rea-
son for the discrepancy between the N-terminal biotin, 
which can get through the -clamp, and the downstream 
stopper biotins that cannot.) As the authors point out, 
an  helix consisting of 33 residues would, at 50 Å, fall 
far short of spanning the 120-Å length of the channel’s 
stem region. But as an extended chain, 33 amino acids 
would span 119 Å, which jibes nicely with the length of 
the stem. The conclusion, therefore, is that LFN translo-
cates as an extended chain.
In contrast to the agreement in cutoff obtained with 
the two types of stoppers applied cis, the biotin and YFP 
stopper constructs behave quite differently when added 
from the trans side. The N terminus of an LFN with a   
biotin stopper is able to enter the trans side of the pore 
and work its way all the way up the stem until the biotin 
heptamers at neutral pH, but at acidic pH and in the 
presence of a lipid bilayer, this heptameric prepore under-
goes a transition into a mushroom-shaped 14-stranded   
 barrel that forms a transmembrane channel (summa-
rized in Young and Collier, 2007). (Although PA63 is 
heptameric in several experimental systems, there is evi-
dence for octamer formation in vivo; Kintzer et al., 2009, 
2010.) The dimensions of this channel can be gleaned 
from  modeling  efforts  (Krantz  et  al.,  2004;  Nguyen, 
2004) as well as from negative-stain electron microscopy 
data (Katayama et al., 2008, 2010) (see Fig. 1 of Basilio   
et al., 2011). The channel is 170-Å long, with a stem 
region that is 100 Å in length and a cap region that is 
70-Å long and 125-Å wide. The inner diameter of the 
pore is 15 Å, which is large enough to accommodate 
the passage of an  helix.
To study translocation through PA63 channels, Zhang   
et al. (2004a,b) leveraged an interesting observation: PA63 
channels can be blocked by LF in a voltage-dependent 
fashion  (for  technical  reasons,  the  authors  chose  to 
work with LFN, the 263-residue N-terminal portion of LF 
that contains a binding site for PA63 channels). At small 
positive voltages (eg +20 mV), the positively charged   
N-terminal  portion  of  LFN  enters  the  channel  and 
blocks conductance; at negative voltages, LFN unblocks 
by coming back out of the channel to the cis solution. 
(By convention, voltages are those of the cis relative to the 
trans sides of the bilayer, with the cis side defined as the 
side to which PA63 is added.) At larger positive voltages 
(e.g., ≥+40 mV), however, the degree of block actually 
decreases. Because the usual interpretation of relief of 
cationic block with larger positive voltages is that the 
blocker is permeant, the authors concluded that LFN is 
driven through the channel and out the trans side in a 
manner reminiscent of the permeant, voltage-dependent 
block of PA63 channels by tetraalkylammonium ions 
(Blaustein and Finkelstein, 1990b; Blaustein et al., 1990). 
To strengthen their translocation argument, the authors 
examined LFN block using biotin tagging and streptavi-
din capture. When an LFN that has been biotinylated at 
its N terminus is used to block PA63 channels, streptavi-
din added to the trans side grabs the N terminus as it 
emerges from the pore and anchors it there so that it 
cannot unblock to the cis side upon application of neg-
ative voltages (Zhang et al., 2004b). Further evidence 
that LFN is going through the PA63 pore, rather than via 
some other route, is that chemical modification of pore-
lining residues slows translocation.
This elegant wedding of the bilayer recording system 
with a biotin-streptavidin assay is an approach pioneered 
by the Finkelstein laboratory in the 1990’s to study trans-
membrane protein movements associated with voltage 
gating of toxin channels (Qiu et al., 1994; Slatin et al., 
1994). It takes advantage of the ease with which one can 
place a biotin residue at a site along a protein, the ex-
tremely tight binding of streptavidin with biotin, and   Blaustein 339
cap domain, and these sites effectively increase the 
potency of LF and EF so that block can be observed at 
concentrations of these A fragments that are achievable 
in solution.
How does translocation through PA63 channels com-
pare to protein translocation in other systems? Although 
voltage can drive translocation in anthrax, pH turns 
out to be a more powerful driving force by creating a 
bias to the otherwise random thermal motion of the 
peptide in the PA63 channel. This Brownian ratchet mech-
anism relies on the deprotonation of anionic residues 
as they exit the channel to the more alkaline trans side, 
making them less likely to reenter the channel’s anionic 
milieu (Krantz et al., 2006). An important component 
of this mechanism is the channel’s -clamp. This ring 
of phenylalanines, which is highly conserved among ho-
mologous toxins, forms a tight seal around the translo-
cating peptide to prevent the pH gradient across the 
endosomal membrane from dissipating. It also catalyzes 
translocation by forming a binding site that mimics the 
hydrophobic core of a protein. As others have pointed 
out (Krantz et al., 2005; von Heijne, 2005), this latter 
function may be similar to the hydrophobic gasket pres-
ent in the Sec61/SecY complex, the “greasy slide” seen in 
the structure of the sugar translocation channel malto-
porin, and the hydrophobic residues that project into 
the central cavity of the GroEL/ES chaperonin. The ex-
tended nature of the polypeptide chain that LFN adopts 
during translocation has also been observed in other 
systems, including transport across the mitochondrial 
membrane (Ungermann et al., 1994) and across the ribo-
some–translocon channel (Whitley et al., 1996; Mingarro 
et al., 2000). In the latter system, amino acid sequence 
plays an important role; peptides can traverse either as 
extended chains or, if their sequence contains residues 
with higher helical propensity, they can adopt a more 
compact helical form during translocation. Thus, the 
mechanism of protein transport in complex mamma-
lian systems, which require auxiliary proteins such as 
ATPases to provide the energy that drives translocation, 
exhibits striking parallels to the mechanism of protein 
transport through the anthrax channel, which is a self-
sufficient protein-translocating machine. It’s a barrel of 
LFs, I tell ya.
I thank Merritt Maduke for insightful comments.
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stopper reaches the -clamp, whereas the YFP stopper 
is unable to enter the stem at all (compare the cartoon 
in Fig. 11 of Basilio et al., 2011, with that in Fig. 12). 
Thus, each stopper yields a different distance measure-
ment; the biotin stopper, with its shorter cutoff, pro-
vides an estimate of the length of the mushroom cap, 
and the YFP stopper, with its longer cutoff range, provides 
an  approximate  readout  of  the  length  of  the  entire 
channel. Although the authors did not attempt to de-
termine cutoffs as finely as with the cis-applied blockers, 
their results agree nicely with the dimensions derived 
from the EM structure.
Is it possible that LFN remains mostly  helical during 
its  passage  through  the  PA63  channel  but  that  trans 
streptavidin, by virtue of its ability to bind biotin nearly 
irreversibly, captures a rare extended configuration of 
LFN? This is a problem that can plague attempts to draw 
structural insights using approaches that rely on irre-
versibly trapping a particular conformation of a protein 
(disulfide cross-linking in proteins is a well-known ex-
ample; Falke and Koshland, 1987; Careaga and Falke, 
1992). In this case, a comparison of the kinetics of strep-
tavidin capture for different blockers provides impor-
tant insight and suggests that this is very unlikely. Using 
a reductio ad absurdum argument, the authors set up the 
straw man assumption that LFN remains mostly  helical 
and  only  rarely  adopts  an  extended  conformation.   
A YFP blocker with 83 residues between its stopper and 
the N terminus would just span the stem region, and its 
N-terminal biotin would just be accessible to trans strep-
tavidin. A blocker with 40 fewer residues between its 
stopper and N-terminal biotin would, if  helical, span 
a distance that is 60-Å shorter, and it would very rarely 
adopt a configuration for which its N terminus reached 
the trans solution. Therefore, the N-terminal biotin of 
the shorter blocker should be captured by streptavidin 
only very rarely and therefore at a much slower rate 
than that of the longer blocker (by a factor roughly pro-
portional to the time it spends extended vs. helical). But 
the observed rates of streptavidin capture for these two 
blockers actually differ by only a factor of 2, thus gener-
ating a contradiction. The authors conclude, therefore, 
that  LFN  is  extended  during  translocation  and  that 
streptavidin is not capturing a rare configuration.
Why is anthrax the only A/B toxin for which translo-
cation has convincingly been demonstrated? The an-
swer likely lies in several unique features of this toxin. 
In other A/B toxins, the A and B domains are part of a 
single  protein  and  therefore  when  purified  toxin  is 
added to a lipid bilayer, channel formation and translo-
cation occur nearly simultaneously. But because PA, 
LF, and EF of anthrax toxin are synthesized de novo as 
individual proteins, channel formation and transloca-
tion can be readily dissociated. Furthermore, channels 
formed by PA63 contain binding sites for LF and EF, 
both in the pore and on the surface of the mushroom 340 The anthrax toxin channel: a barrel of LFs
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